Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,131.60
(
-0.27%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
94.45
(
2.17%
)
Bitcoin
74,234.99
(
-0.87%
)
News Focus
News Focus
Post# of 26662
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

retired early

Send PM Follow Ignore
Followers 84
Posts 5681
Boards Moderated 0
Alias Born 11/29/2016

retired early

Re: None

Wednesday, 05/28/2025 9:01:06 AM

Wednesday, May 28, 2025 9:01:06 AM

Post# of 26662
JACKSON CENTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy for our patent-pending LDX compound for dialysis-borne neuropathy and pruritis in yet another case report and issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent HALB News
More HALB News